These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 27764535)

  • 1. Evaluation of species difference in peripheral lymphocyte reduction effect of CS-0777, a sphingosine 1-phosphate receptor modulator, based on a pharmacokinetic/pharmacodynamic model analysis.
    Inaba SI; Goto M; Tanaka-Takanaka K; Tanaka H; Tomisato W; Yuita H; Doi-Komuro H; Inoue R; Oshima K; Kagari T; Shimozato T; Izumi T
    Biopharm Drug Dispos; 2016 Dec; 37(9):561-573. PubMed ID: 27764535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of an exposure-response model to aid early drug development of an oral sphingosine 1-phosphate receptor modulator.
    Rohatagi S; Zahir H; Moberly JB; Truitt KE; Inaba S; Shimozato T; Carrothers TJ
    J Clin Pharmacol; 2009 Jan; 49(1):50-62. PubMed ID: 18948412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics and disposition of CS-0777, a sphingosine 1-phosphate receptor modulator, in rats and monkeys.
    Inaba S; Ikeda T; Goto M; Tanaka H; Takahashi M; Iwabuchi H; Izumi T
    Xenobiotica; 2015; 45(12):1063-80. PubMed ID: 26084376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prediction of human response to ONO-4641, a sphingosine 1-phosphate receptor modulator, from preclinical data based on pharmacokinetic-pharmacodynamic modeling.
    Ohno T; Hasegawa C; Nakade S; Kitagawa J; Honda N; Ogawa M
    Biopharm Drug Dispos; 2010 Oct; 31(7):396-406. PubMed ID: 20623701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological modulation of peripheral T and B lymphocytes by a selective sphingosine 1-phosphate receptor-1 modulator.
    Moberly JB; Rohatagi S; Zahir H; Hsu C; Noveck RJ; Truitt KE
    J Clin Pharmacol; 2012 Jul; 52(7):996-1006. PubMed ID: 21566200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a selective S1P1 receptor agonist, Syl930, as a potential therapeutic agent for autoimmune encephalitis.
    Jin J; Hu J; Zhou W; Wang X; Xiao Q; Xue N; Yin D; Chen X
    Biochem Pharmacol; 2014 Jul; 90(1):50-61. PubMed ID: 24780445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and evaluation of CS-2100, a potent, orally active and S1P(3)- sparing S1P(1) agonist.
    Nakamura T; Asano M; Sekiguchi Y; Mizuno Y; Tamaki K; Nara F; Kawase Y; Yabe Y; Nakai D; Kamiyama E; Urasaki-Kaneno Y; Shimozato T; Doi-Komuro H; Kagari T; Tomisato W; Inoue R; Nagasaki M; Yuita H; Oguchi-Oshima K; Kaneko R; Nishi T
    Eur J Med Chem; 2012 May; 51():92-8. PubMed ID: 22405291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FTY720, sphingosine 1-phosphate receptor modulator, ameliorates experimental autoimmune encephalomyelitis by inhibition of T cell infiltration.
    Kataoka H; Sugahara K; Shimano K; Teshima K; Koyama M; Fukunari A; Chiba K
    Cell Mol Immunol; 2005 Dec; 2(6):439-48. PubMed ID: 16426494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetic/pharmacodynamic modelling of 2-acetyl-4(5)-tetrahydroxybutyl imidazole-induced peripheral lymphocyte sequestration through increasing lymphoid sphingosine 1-phosphate.
    Yu XQ; Kramer J; Moran L; O'Neill E; Nouraldeen A; Oravecz T; Wilson AG
    Xenobiotica; 2010 May; 40(5):350-6. PubMed ID: 20175664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The selective sphingosine 1-phosphate receptor 1 agonist ponesimod protects against lymphocyte-mediated tissue inflammation.
    Piali L; Froidevaux S; Hess P; Nayler O; Bolli MH; Schlosser E; Kohl C; Steiner B; Clozel M
    J Pharmacol Exp Ther; 2011 May; 337(2):547-56. PubMed ID: 21345969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The selective sphingosine 1-phosphate receptor modulator BAF312 redirects lymphocyte distribution and has species-specific effects on heart rate.
    Gergely P; Nuesslein-Hildesheim B; Guerini D; Brinkmann V; Traebert M; Bruns C; Pan S; Gray NS; Hinterding K; Cooke NG; Groenewegen A; Vitaliti A; Sing T; Luttringer O; Yang J; Gardin A; Wang N; Crumb WJ; Saltzman M; Rosenberg M; Wallström E
    Br J Pharmacol; 2012 Nov; 167(5):1035-47. PubMed ID: 22646698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological effects of CS-0777, a selective sphingosine 1-phosphate receptor-1 modulator: results from a 12-week, open-label pilot study in multiple sclerosis patients.
    Moberly JB; Ford DM; Zahir H; Chen S; Mochizuki T; Truitt KE; Vollmer TL
    J Neuroimmunol; 2012 May; 246(1-2):100-7. PubMed ID: 22465063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A potent and selective S1P(1) antagonist with efficacy in experimental autoimmune encephalomyelitis.
    Quancard J; Bollbuck B; Janser P; Angst D; Berst F; Buehlmayer P; Streiff M; Beerli C; Brinkmann V; Guerini D; Smith PA; Seabrook TJ; Traebert M; Seuwen K; Hersperger R; Bruns C; Bassilana F; Bigaud M
    Chem Biol; 2012 Sep; 19(9):1142-51. PubMed ID: 22999882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enzymatic kinetics regarding reversible metabolism of CS-0777, a sphingosine 1-phosphate receptor modulator, via phosphorylation and dephosphorylation in humans.
    Inaba SI; Yamaguchi-Goto M; Tanaka-Takanaka K; Yonesu K; Sakurai H; Kubota K; Izumi T
    Xenobiotica; 2018 Mar; 48(3):258-268. PubMed ID: 28287856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amiselimod, a novel sphingosine 1-phosphate receptor-1 modulator, has potent therapeutic efficacy for autoimmune diseases, with low bradycardia risk.
    Sugahara K; Maeda Y; Shimano K; Mogami A; Kataoka H; Ogawa K; Hikida K; Kumagai H; Asayama M; Yamamoto T; Harada T; Ni P; Inoue S; Kawaguchi A
    Br J Pharmacol; 2017 Jan; 174(1):15-27. PubMed ID: 27714763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery and Structure-Activity Relationship (SAR) of a Series of Ethanolamine-Based Direct-Acting Agonists of Sphingosine-1-phosphate (S1P1).
    Gilmore JL; Sheppeck JE; Watterson SH; Haque L; Mukhopadhyay P; Tebben AJ; Galella MA; Shen DR; Yarde M; Cvijic ME; Borowski V; Gillooly K; Taylor T; McIntyre KW; Warrack B; Levesque PC; Li JP; Cornelius G; D'Arienzo C; Marino A; Balimane P; Salter-Cid L; Barrish JC; Pitts WJ; Carter PH; Xie J; Dyckman AJ
    J Med Chem; 2016 Jul; 59(13):6248-64. PubMed ID: 27309907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brain penetration of the oral immunomodulatory drug FTY720 and its phosphorylation in the central nervous system during experimental autoimmune encephalomyelitis: consequences for mode of action in multiple sclerosis.
    Foster CA; Howard LM; Schweitzer A; Persohn E; Hiestand PC; Balatoni B; Reuschel R; Beerli C; Schwartz M; Billich A
    J Pharmacol Exp Ther; 2007 Nov; 323(2):469-75. PubMed ID: 17682127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of Tricyclic Agonists of Sphingosine-1-phosphate Receptor 1 (S1P
    Xiao HY; Watterson SH; Langevine CM; Srivastava AS; Ko SS; Zhang Y; Cherney RJ; Guo WW; Gilmore JL; Sheppeck JE; Wu DR; Li P; Ramasamy D; Arunachalam P; Mathur A; Taylor TL; Shuster DJ; McIntyre KW; Shen DR; Yarde M; Cvijic ME; Marino AM; Balimane PV; Yang Z; Banas DM; Cornelius G; D'Arienzo CJ; Warrack BM; Lehman-McKeeman L; Salter-Cid LM; Xie J; Barrish JC; Carter PH; Dyckman AJ; Dhar TG
    J Med Chem; 2016 Nov; 59(21):9837-9854. PubMed ID: 27726358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of novel 1,2,4-thiadiazole derivatives as potent, orally active agonists of sphingosine 1-phosphate receptor subtype 1 (S1P(1)).
    Ren F; Deng G; Wang H; Luan L; Meng Q; Xu Q; Xu H; Xu X; Zhang H; Zhao B; Li C; Guo TB; Yang J; Zhang W; Zhao Y; Jia Q; Lu H; Xiang JN; Elliott JD; Lin X
    J Med Chem; 2012 May; 55(9):4286-96. PubMed ID: 22500954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modeling the Effect of the Selective S1P
    Lott D; Krause A; Seemayer CA; Strasser DS; Dingemanse J; Lehr T
    Pharm Res; 2017 Mar; 34(3):599-609. PubMed ID: 28028771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.